跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
人血白蛋白 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Human Albumin
Approved
生物制品
Human Albumin
Takeda Manufacturing Austria AG
🇨🇳 National Medical Products Administration
Approval Date
Mar 21, 2023
Approval ID
8TELtp1SjQb
Company
Takeda Manufacturing Austria AG
Type
生物制品
Approval Details
Approval Id
8TELtp1SjQb
Approval Number
国药准字SJ20160018
Generic Name
人血白蛋白
Generic Name En
Human Albumin
Drug Type
生物制品
Dosage Form
注射剂
Strength
10g/瓶(20%,50ml)
Reg Date
2023-03-21
Expired Date
2028-03-20
Company Name
Takeda Manufacturing Austria AG
Production Company Name
Takeda Manufacturing Austria AG
Company Detail Path
/organization/takeda-manufacturing-austria-ag
Production Company Detail Path
/organization/takeda-manufacturing-austria-ag
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 21, 2023
Approval ID
8TELtp1SjQb
Type
生物制品
Back to NMPA Approvals